Winning Health Technology Group Gelecekteki Büyüme

Future kriter kontrolleri 4/6

Winning Health Technology Group kazanç ve gelirin sırasıyla yıllık 34.9% ve 19.2% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 34.8% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 10.2% olacağı tahmin edilmektedir.

Anahtar bilgiler

34.9%

Kazanç büyüme oranı

34.8%

EPS büyüme oranı

Healthcare Services kazanç büyümesi	30.1%
Gelir büyüme oranı	19.2%
Gelecekteki özkaynak getirisi	10.2%
Analist kapsamı	Good
Son güncelleme	01 Nov 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

There May Be Underlying Issues With The Quality Of Winning Health Technology Group's (SZSE:300253) Earnings

Nov 05

Winning Health Technology Group Co., Ltd. (SZSE:300253) Held Back By Insufficient Growth Even After Shares Climb 39%

Oct 10

Winning Health Technology Group (SZSE:300253) May Have Issues Allocating Its Capital

Aug 22

These 4 Measures Indicate That Winning Health Technology Group (SZSE:300253) Is Using Debt Reasonably Well

Jul 03

Impressive Earnings May Not Tell The Whole Story For Winning Health Technology Group (SZSE:300253)

May 03

Is Winning Health Technology Group (SZSE:300253) A Risky Investment?

Mar 19

Winning Health Technology Group Co., Ltd. (SZSE:300253) Held Back By Insufficient Growth Even After Shares Climb 25%

Mar 01

Returns On Capital At Winning Health Technology Group (SZSE:300253) Paint A Concerning Picture

Feb 28

Kazanç ve Gelir Büyüme Tahminleri

SZSE:300253 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (CNY Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
12/31/2026	4,835	794	N/A	773	8
12/31/2025	4,121	638	N/A	450	9
12/31/2024	3,331	429	N/A	726	3
9/30/2024	3,176	360	39	339	N/A
6/30/2024	3,195	372	61	385	N/A
3/31/2024	3,209	438	-134	168	N/A
12/31/2023	3,163	358	-129	185	N/A
9/30/2023	3,123	121	-253	82	N/A
6/30/2023	3,189	58	-296	24	N/A
3/31/2023	3,097	13	-234	107	N/A
1/1/2023	3,093	109	-223	100	N/A
9/30/2022	2,858	258	54	379	N/A
6/30/2022	2,822	333	143	461	N/A
3/31/2022	2,851	396	171	468	N/A
1/1/2022	2,750	378	82	368	N/A
9/30/2021	2,658	547	106	332	N/A
6/30/2021	2,498	528	112	312	N/A
3/31/2021	2,333	494	212	406	N/A
12/31/2020	2,267	491	203	390	N/A
9/30/2020	2,082	329	81	270	N/A
6/30/2020	2,032	311	-4	213	N/A
3/31/2020	1,939	353	13	213	N/A
12/31/2019	1,908	398	42	233	N/A
9/30/2019	1,712	384	-61	117	N/A
6/30/2019	1,561	347	30	194	N/A
3/31/2019	1,480	320	-6	161	N/A
12/31/2018	1,439	303	-43	124	N/A
9/30/2018	1,439	288	-93	91	N/A
6/30/2018	1,330	259	N/A	27	N/A
3/31/2018	1,242	243	N/A	-22	N/A
12/31/2017	1,204	229	N/A	80	N/A
9/30/2017	1,059	193	N/A	-57	N/A
6/30/2017	1,011	184	N/A	-26	N/A
3/31/2017	987	523	N/A	121	N/A
12/31/2016	954	519	N/A	140	N/A
9/30/2016	901	522	N/A	158	N/A
6/30/2016	852	517	N/A	101	N/A
3/31/2016	791	158	N/A	26	N/A
12/31/2015	753	153	N/A	79	N/A
9/30/2015	647	142	N/A	-48	N/A
6/30/2015	607	142	N/A	8	N/A
3/31/2015	536	127	N/A	22	N/A
12/31/2014	491	121	N/A	43	N/A
9/30/2014	402	100	N/A	62	N/A
6/30/2014	374	91	N/A	41	N/A
3/31/2014	358	84	N/A	47	N/A
12/31/2013	349	81	N/A	50	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: 300253 'nin tahmini kazanç büyümesi (yıllık 34.9% ) tasarruf oranının ( 2.8% ) üzerindedir.

Kazançlar ve Piyasa: 300253 şirketinin kazançlarının (yıllık 34.9% ) CN pazarından (yıllık 26.2% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: 300253 şirketinin kazançlarının önümüzdeki 3 yıl içerisinde önemli ölçüde artması bekleniyor.

Gelir ve Pazar: 300253 şirketinin gelirinin (yıllık 19.2% ) CN pazarından (yıllık 13.8% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: 300253 şirketinin gelirinin (yıllık 19.2% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: 300253 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 10.2 %).

Winning Health Technology Group Gelecekteki Büyüme

Future kriter kontrolleri 4/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Price target increased by 13% to CN¥8.83

Price target decreased by 9.5% to CN¥8.14

Price target increased by 12% to CN¥9.08

Price target decreased by 7.5% to CN¥9.29

Consensus revenue estimates fall by 10%

Price target increased by 8.5% to CN¥12.35

Recent updates

There May Be Underlying Issues With The Quality Of Winning Health Technology Group's (SZSE:300253) Earnings

Price target increased by 13% to CN¥8.83

Third quarter 2024 earnings released: EPS: CN¥0.057 (vs CN¥0.064 in 3Q 2023)

Investor sentiment deteriorates as stock falls 17%

Winning Health Technology Group Co., Ltd. (SZSE:300253) Held Back By Insufficient Growth Even After Shares Climb 39%

New minor risk - Share price stability

Winning Health Technology Group Co., Ltd. to Report Q3, 2024 Results on Oct 30, 2024

Investor sentiment improves as stock rises 17%

Price target decreased by 9.5% to CN¥8.14

Second quarter 2024 earnings released: EPS: CN¥0.006 (vs CN¥0.037 in 2Q 2023)

Winning Health Technology Group (SZSE:300253) May Have Issues Allocating Its Capital

These 4 Measures Indicate That Winning Health Technology Group (SZSE:300253) Is Using Debt Reasonably Well

Winning Health Technology Group Co., Ltd. to Report First Half, 2024 Results on Aug 29, 2024

Dividend increased to CN¥0.02

Impressive Earnings May Not Tell The Whole Story For Winning Health Technology Group (SZSE:300253)

First quarter 2024 earnings released: EPS: CN¥0.008 (vs CN¥0.03 loss in 1Q 2023)

Full year 2023 earnings: EPS and revenues miss analyst expectations

Winning Health Technology Group Co., Ltd., Annual General Meeting, May 10, 2024

Price target increased by 12% to CN¥9.08

Winning Health Technology Group Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024

Is Winning Health Technology Group (SZSE:300253) A Risky Investment?

Winning Health Technology Group Co., Ltd. (SZSE:300253) Held Back By Insufficient Growth Even After Shares Climb 25%

Returns On Capital At Winning Health Technology Group (SZSE:300253) Paint A Concerning Picture

Winning Health Technology Group Co., Ltd. to Report Fiscal Year 2023 Results on Apr 13, 2024

Price target decreased by 7.5% to CN¥9.29

Third quarter 2023 earnings: Revenues and EPS in line with analyst expectations

Consensus revenue estimates fall by 10%

Second quarter 2023 earnings: Revenues and EPS in line with analyst expectations

Winning Health Technology Group Co., Ltd. to Report First Half, 2023 Results on Aug 18, 2023

Winning Health Technology Group Co., Ltd. Announces Final Dividend Implementation on Share A for 2022, Payable on June 15, 2023

Price target increased by 8.5% to CN¥12.35

Full year 2022 earnings: EPS and revenues miss analyst expectations

Price target increased to CN¥10.04

Less than half of directors are independent

Consensus EPS estimates fall by 62%

Third quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.016 (vs CN¥0.046 in 2Q 2021)

Winning Health Technology Group Co., Ltd. Announces Final Dividend on A Shares for the Year 2021, Payable on July 15, 2022

Winning Health Technology Group Co., Ltd. Announces Final Dividend for 2021

Consensus EPS estimates fall by 23%

Price target decreased to CN¥11.04

First quarter 2022 earnings: EPS misses analyst expectations

Less than half of directors are independent

Winning Health Technology Group Co., Ltd. Proposes Final Dividend for 2021

Now 20% undervalued after recent price drop

Now 21% undervalued after recent price drop

Consensus EPS estimates fall by 10%

Price target decreased to CN¥15.54

Investor sentiment deteriorated over the past week

Price target decreased to CN¥15.79

Price target decreased to CN¥17.39

Third quarter 2021 earnings released: EPS CN¥0.07 (vs CN¥0.061 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.046 (vs CN¥0.029 in 2Q 2020)

Full year 2020 earnings released: EPS CN¥0.23 (vs CN¥0.19 in FY 2019)

Winning Health Technology Group Co., Ltd. to Report Fiscal Year 2020 Results on Apr 21, 2021

Price target lowered to CN¥20.45

Winning Health Technology Group Co., Ltd. Announces Board Appointments

New 90-day high: CN¥17.90

New 90-day low: CN¥14.86

New 90-day low: CN¥14.95

New 90-day low: CN¥15.54

New 90-day low: CN¥16.63

New 90-day low: CN¥17.79

Third quarter earnings released

Suqian Jingdong Tianning Health Technology Co., Ltd. and Wuxi AppTec Phase I Investment Enterprise (Limited Partnership) completed the acquisition of 8.6% stake in Shanghai Kingstar Winning Software Technology Co., Ltd. from Zhao Menghai and Winning Health Technology Group Co., Ltd. (SZSE:300253).

Earnings released

Winning Health Technology Group Co., Ltd. to Report First Half, 2020 Results on Aug 27, 2020

Kazanç ve Gelir Büyüme Tahminleri